fda compounding semaglutide enforcement news november 2025 FDA's GLP-1 decision kicks off 'unprecedented' tussle over shortage FDA Warns on Certain Forms

Namely: No longer covering GLP-1s for weight loss : Several insurers have made the choice to stop providing coverage for these drugs when used specifically for weight loss, while still covering them for other uses like diabetes

Future research will define how to optimally use retatrutide alone or in combination with other therapies

It occurs due to disruption of the normal hair follicle growth cycle

After all, she lost weight

General research-grade principles for lyophilised peptide compounds, as informed by ICH Q1A(R2) stability guidelines and standard pharmaceutical practice, include: Temperature: Lyophilised peptide powder is typically stored at 20C (deep freeze) for long-term storage in research settings

The TRIUMPH-4 data reveal that nearly 1 in 4 patients on the highest dose lost 35% of body weight, not just the average ~28.7%